Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
11.4M
-
Shares change
-
+11.1M
-
Total reported value, excl. options
-
$471M
-
Value change
-
+$461M
-
Number of buys
-
44
-
Price
-
$41.50
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q2 2015
45 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q2 2015.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.4M shares
of 170M outstanding shares and own 6.68% of the company stock.
Largest 10 shareholders include FMR LLC (5.24M shares), PRICE T ROWE ASSOCIATES INC /MD/ (961K shares), BlackRock Advisors LLC (648K shares), Flagship Ventures 2007 General Partner LLC (599K shares), TimesSquare Capital Management, LLC (410K shares), JENNISON ASSOCIATES LLC (390K shares), Capital World Investors (375K shares), WADDELL & REED FINANCIAL INC (301K shares), ORBIMED ADVISORS LLC (247K shares), and RA CAPITAL MANAGEMENT, LLC (247K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.